London stocks fall as AstraZeneca trial setback hits FTSE 100
FTSE 100 fell about 0.5% on Thursday, pressured by a slump in AstraZeneca, while gains in miners and some mid-caps helped limit losses. The FTSE 250 rose 0.4%, according to Hargreaves Lansdown data. Parts of Europe traded firmer.
